UCLA’s Chi On Chui has developed a device that brings lab quality bio-molecular assessments to point-of-care settings, such as clinics, ambulances or homes.
SELFA (Semiconductor Electronic Label-Free Assay) could reduce emergency room time for heart attack patients by hours. Similar to a diabetic glucose sensor, SELFA uses a single drop of blood, taken wherever symptoms occur, to determine which patients do not require further medical care.
According to Chui: “Eighty-five percent of patients who present with symptoms of acute coronary syndrome in emergency rooms across the U.S. and Europe — some 12.75 million per year — have actually not had heart attacks after a standard test comes back, hours later, from the lab.”
WEARABLE TECH + DIGITAL HEALTH SAN FRANCISCO – APRIL 5, 2016 – REGISTER HERE
NEUROTECH SAN FRANCISCO – APRIL 6, 2016 – REGISTER HERE